Abstract
RATIONALE: Innovative aerosol generators can improve nebulization efficiency of aqueous suspensions by eliminating large residual volumes and concentrating effects associated with jet nebulizers. A novel submicron budesonide dispersion (sBUD) has been developed for use with these innovative aerosol generators, which are not approved for use with marketed aqueous suspensions used to treat of pediatric asthma.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
